Bosh sahifa207940 • KRX
add
Samsung Biologics Co Ltd
Yopilish kursi
1 514 000,00 ₩
Kunlik diapazon
1 514 000,00 ₩ - 1 533 000,00 ₩
Yillik diapazon
982 000,00 ₩ - 1 987 000,00 ₩
Bozor kapitalizatsiyasi
70,73 trln KRW
Oʻrtacha hajm
43,37 ming
Narx/foyda
41,25
Dividend daromadliligi
-
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | mar, 2026info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,26 trln | -3,18% |
Joriy xarajat | 99,00 mlrd | -58,99% |
Sof foyda | 469,00 mlrd | 24,88% |
Sof foyda marjasi | 37,31 | 28,97% |
Har bir ulushga tushum | — | — |
EBITDA | — | — |
Amaldagi soliq stavkasi | 26,83% | — |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | mar, 2026info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,62 trln | 26,05% |
Jami aktivlari | 12,00 trln | -31,21% |
Jami passivlari | 4,07 trln | -33,86% |
Umumiy kapital | 7,92 trln | — |
Tarqatilgan aksiyalar | — | — |
Narxi/balansdagi bahosi | — | — |
Aktivlardan daromad | 12,60% | — |
Kapitaldan daromad | 16,88% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (KRW) | mar, 2026info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 469,00 mlrd | 24,88% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
CEO
Tashkil etilgan
2011
Xodimlar soni
4 770
